rs72841138

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004946.3(DOCK2):​c.843+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0455 in 1,613,588 control chromosomes in the GnomAD database, including 1,883 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.049 ( 186 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1697 hom. )

Consequence

DOCK2
NM_004946.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0003419
2

Clinical Significance

Benign criteria provided, single submitter B:1O:1

Conservation

PhyloP100: 1.21

Publications

3 publications found
Variant links:
Genes affected
DOCK2 (HGNC:2988): (dedicator of cytokinesis 2) The protein encoded by this gene belongs to the CDM protein family. It is specifically expressed in hematopoietic cells and is predominantly expressed in peripheral blood leukocytes. The protein is involved in remodeling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signaling. It activates members of the Rho family of GTPases, for example RAC1 and RAC2, by acting as a guanine nucleotide exchange factor (GEF) to exchange bound GDP for free GTP. Mutations in this gene result in immunodeficiency 40 (IMD40), a combined form of immunodeficiency that affects T cell number and function, also with variable defects in B cell and NK cell function. [provided by RefSeq, May 2018]
DOCK2 Gene-Disease associations (from GenCC):
  • DOCK2 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-169689340-G-A is Benign according to our data. Variant chr5-169689340-G-A is described in ClinVar as [Benign]. Clinvar id is 476020.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0663 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK2NM_004946.3 linkc.843+7G>A splice_region_variant, intron_variant Intron 9 of 51 ENST00000520908.7 NP_004937.1 Q92608-1Q5XG91

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK2ENST00000520908.7 linkc.843+7G>A splice_region_variant, intron_variant Intron 9 of 51 2 NM_004946.3 ENSP00000429283.3 Q92608-1
DOCK2ENST00000524185.5 linkn.843+7G>A splice_region_variant, intron_variant Intron 9 of 52 1 ENSP00000428850.1 E5RFJ0
DOCK2ENST00000519628.2 linkc.843+7G>A splice_region_variant, intron_variant Intron 9 of 27 3 ENSP00000428841.2 H0YB76
DOCK2ENST00000522138.2 linkn.*353+7G>A splice_region_variant, intron_variant Intron 9 of 51 3 ENSP00000512484.1 A0A8Q3WL64

Frequencies

GnomAD3 genomes
AF:
0.0490
AC:
7453
AN:
152088
Hom.:
186
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0685
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0384
Gnomad ASJ
AF:
0.0585
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0172
Gnomad FIN
AF:
0.0254
Gnomad MID
AF:
0.0446
Gnomad NFE
AF:
0.0490
Gnomad OTH
AF:
0.0478
GnomAD2 exomes
AF:
0.0390
AC:
9782
AN:
250966
AF XY:
0.0377
show subpopulations
Gnomad AFR exome
AF:
0.0707
Gnomad AMR exome
AF:
0.0326
Gnomad ASJ exome
AF:
0.0556
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0304
Gnomad NFE exome
AF:
0.0482
Gnomad OTH exome
AF:
0.0506
GnomAD4 exome
AF:
0.0451
AC:
65891
AN:
1461382
Hom.:
1697
Cov.:
30
AF XY:
0.0443
AC XY:
32195
AN XY:
727018
show subpopulations
African (AFR)
AF:
0.0716
AC:
2395
AN:
33464
American (AMR)
AF:
0.0332
AC:
1486
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0577
AC:
1509
AN:
26134
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39680
South Asian (SAS)
AF:
0.0172
AC:
1479
AN:
86230
European-Finnish (FIN)
AF:
0.0333
AC:
1781
AN:
53414
Middle Eastern (MID)
AF:
0.0566
AC:
321
AN:
5672
European-Non Finnish (NFE)
AF:
0.0488
AC:
54236
AN:
1111696
Other (OTH)
AF:
0.0444
AC:
2681
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
2946
5891
8837
11782
14728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1974
3948
5922
7896
9870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0490
AC:
7459
AN:
152206
Hom.:
186
Cov.:
32
AF XY:
0.0468
AC XY:
3487
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0684
AC:
2840
AN:
41530
American (AMR)
AF:
0.0384
AC:
587
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0585
AC:
203
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0172
AC:
83
AN:
4822
European-Finnish (FIN)
AF:
0.0254
AC:
269
AN:
10604
Middle Eastern (MID)
AF:
0.0514
AC:
15
AN:
292
European-Non Finnish (NFE)
AF:
0.0490
AC:
3331
AN:
67990
Other (OTH)
AF:
0.0473
AC:
100
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
352
704
1057
1409
1761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0457
Hom.:
109
Bravo
AF:
0.0520
Asia WGS
AF:
0.0120
AC:
41
AN:
3476
EpiCase
AF:
0.0527
EpiControl
AF:
0.0496

ClinVar

Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

DOCK2 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
9.4
DANN
Benign
0.73
PhyloP100
1.2
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00034
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72841138; hg19: chr5-169116344; API